![Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment](https://f6publishing.blob.core.windows.net/227ae865-2d6c-40e1-9cb2-2abecf2b4b26/WJGS-13-1463-g001.png)
Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment
![Long-term overall survival of Stage I–III. L: laparoscopic, O: open,... | Download Scientific Diagram Long-term overall survival of Stage I–III. L: laparoscopic, O: open,... | Download Scientific Diagram](https://www.researchgate.net/publication/341302431/figure/fig1/AS:890236376711176@1589260300266/Long-term-overall-survival-of-Stage-I-III-L-laparoscopic-O-open-S1-stage-I-S2_Q640.jpg)
Long-term overall survival of Stage I–III. L: laparoscopic, O: open,... | Download Scientific Diagram
![Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients - Annals of Oncology Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/9ad7f620-1262-4b94-a29e-0d9ea5ea9811/gr1.jpg)
Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients - Annals of Oncology
![High serum angiogenin at diagnosis predicts for failure on long-term treatment response and for poor overall survival in non-Hodgkin lymphoma - European Journal of Cancer High serum angiogenin at diagnosis predicts for failure on long-term treatment response and for poor overall survival in non-Hodgkin lymphoma - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/38822d0f-eeb8-4a30-8e87-9f7116794ba1/gr1.jpg)
High serum angiogenin at diagnosis predicts for failure on long-term treatment response and for poor overall survival in non-Hodgkin lymphoma - European Journal of Cancer
![Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-018-0061-6/MediaObjects/41416_2018_61_Fig1_HTML.jpg)
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer
![Long-term survival results of minimally invasive surgery in patients with uterine serous carcinoma - Gynecologic Oncology Long-term survival results of minimally invasive surgery in patients with uterine serous carcinoma - Gynecologic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/e7771609-811b-42b7-8abf-45232452b6b2/fx44.jpg)
Long-term survival results of minimally invasive surgery in patients with uterine serous carcinoma - Gynecologic Oncology
![P119 Impact of Treatment Modality on Long-Term Survival of Small-Cell Lung Cancer with IA Stage: a Population-based Study - Journal of Thoracic Oncology P119 Impact of Treatment Modality on Long-Term Survival of Small-Cell Lung Cancer with IA Stage: a Population-based Study - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b47137e9-afe7-44af-a1ed-ccbd3bc93eb3/fx1_lrg.jpg)
P119 Impact of Treatment Modality on Long-Term Survival of Small-Cell Lung Cancer with IA Stage: a Population-based Study - Journal of Thoracic Oncology
![Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma - Journal of Pediatric Surgery Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma - Journal of Pediatric Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2004308775/2017921392/gr1.jpg)
Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma - Journal of Pediatric Surgery
![Survival and Prognostic Factors in Children with Brain Tumors: Long-term Follow-up Single Center Study in Poland | Anticancer Research Survival and Prognostic Factors in Children with Brain Tumors: Long-term Follow-up Single Center Study in Poland | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/34/1/323/F1.large.jpg)
Survival and Prognostic Factors in Children with Brain Tumors: Long-term Follow-up Single Center Study in Poland | Anticancer Research
![177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial ... 177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5472aa13-b2e9-4d1c-8ab0-5337cf601f44/gr1.gif)
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial ...
![Long-term survival evaluation. a Overall survival. b Progression-free... | Download Scientific Diagram Long-term survival evaluation. a Overall survival. b Progression-free... | Download Scientific Diagram](https://www.researchgate.net/profile/Frederic-Maloisel/publication/349003983/figure/fig1/AS:987130947981312@1612361766137/Long-term-survival-evaluation-a-Overall-survival-b-Progression-free-survival-c.png)
Long-term survival evaluation. a Overall survival. b Progression-free... | Download Scientific Diagram
![Long-term overall survival in patients with gastric cancer missed at... | Download Scientific Diagram Long-term overall survival in patients with gastric cancer missed at... | Download Scientific Diagram](https://www.researchgate.net/publication/356167780/figure/fig2/AS:1089308777820163@1636722859595/Long-term-overall-survival-in-patients-with-gastric-cancer-missed-at-upper-endoscopy-or.png)
Long-term overall survival in patients with gastric cancer missed at... | Download Scientific Diagram
![JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme](https://dm5migu4zj3pb.cloudfront.net/manuscripts/138000/138649/medium/JCI138649.f7.jpg)
JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme
![Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial - European Urology Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/cdbf89c3-efeb-47c6-be6f-237ffedd1305/gr1.jpg)
Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial - European Urology
![Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma | Anticancer Research Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/35/11/6303/F1.large.jpg)
Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma | Anticancer Research
![Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER | British Journal of Cancer Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbjc.2014.174/MediaObjects/41416_2014_Article_BFbjc2014174_Fig2_HTML.jpg)
Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER | British Journal of Cancer
![Journal of Clinical Oncology on Twitter: "A new benchmark: the GEM20110714 study reports long-term overall survival improvement with gemcitabine/cisplatin compared to fluorouracil/cisplatin in recurrent/metastatic nasopharyngeal carcinoma https://t.co ... Journal of Clinical Oncology on Twitter: "A new benchmark: the GEM20110714 study reports long-term overall survival improvement with gemcitabine/cisplatin compared to fluorouracil/cisplatin in recurrent/metastatic nasopharyngeal carcinoma https://t.co ...](https://pbs.twimg.com/media/E9LKYRRXEAEq0Qq.jpg)
Journal of Clinical Oncology on Twitter: "A new benchmark: the GEM20110714 study reports long-term overall survival improvement with gemcitabine/cisplatin compared to fluorouracil/cisplatin in recurrent/metastatic nasopharyngeal carcinoma https://t.co ...
![Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/3b4b3b7f-ef3e-49b2-b1e3-89793b6a8627/gr1.jpg)
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology
![Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment](https://f6publishing.blob.core.windows.net/227ae865-2d6c-40e1-9cb2-2abecf2b4b26/WJGS-13-1463-g005.png)